IAG Announce FDA 510(k) Clearance for Dynamika Platform
IAG, Image Analysis Group are pleased to announce the FDA (U.S. Food and Drug Administration) 510(k) clearance of their proprietary cloud-based software platform DYNAMIKA.
DYNAMIKA is a powerful cloud platform for management, review and automated scoring of imaging data in clinical trials. It has been cleared by the FDA for the display, analysis and post-processing of medical images.
In clinical trials, DYNAMIKA provides the users with the workflow-based Electronic Data Management system to allow for efficient transport, quality control and audit trail of the images.
DYNAMIKA also incorporates a rich collection of image scoring methodologies – both criteria-based (RECIST) and automated routines for quantitative image analysis.
This is a unique all-in-one solution for the imaging data management and image review, which has been praised by many biopharmaceutical sponsors, physicians and radiologists.
At the American Society of Clinical Oncology (ASCO) annual meeting, IAG’s team will be demonstrating efficiency of DYNAMIKA’s data management as well as comparing the ability of the criteria-based scoring systems (like RECIST) with the advanced image analysis methodologies in assessing the efficacy of oncology and immuno-oncology treatments.
Dynamika Version 5.0 is an image processing software package to be used by trained medical professionals with a level of medical expertise (including physicians, radiographers and radiology technicians). The software is compliant with the DICOM standard and is suitable for running on Windows, Macintosh or Linux operating systems. It can run on a standard off-the-shelf workstation and can be used to perform image viewing, processing and analysis of medical images. Dynamika provides both viewing and analysis capabilities of dynamic imaging datasets acquired with MRI, showing the properties of changes in contrast over time. The package may be used to calculate permeability parameters related to the leakage of injected contrast material from intravascular to extracellular space. Parametric maps may be overlaid onto the original image for interpretation. Dynamika Version 5.0 is intended to be used within hospitals and medical clinics. It is licensed and not intended for general public use.
About Image Analysis Group (IAG)
IAG, Image Analysis Group is a unique partner to life sciences companies. IAG leverages expertise in medical imaging and the power of Dynamika™ – our proprietary cloud-based platform, to de-risk clinical development and deliver lifesaving therapies into the hands of patients much sooner. IAG provides early drug efficacy assessments, smart patient recruitment and predictive analysis of advanced treatment manifestations, thus lowering investment risk and accelerating study outcomes. IAG bio-partnering takes a broader view on asset development bringing R&D solutions, operational breadth, radiological expertise via risk-sharing financing and partnering models.
Learn more: www.ia-grp.com
Reach out: firstname.lastname@example.org
Follow the Company: Linkedin
Join us at BIO International Convention in Boston 5th-8th June 2023
Drug development ideas in osteoarthritis, psoriatic arthritis and scleroderma.
The Invitation-only network for founders &CEOs of the most successful scaleups.